| Catalog Number: | ab11844 |
| Product Name: | VEGF antibody, prediluted |
| Short Description: | Rabbit polyclonal to VEGF, prediluted |
| Clone Number: | request info |
| Clonality: | polyclonal |
| Concentration: | request info |
| Notes: | request info |
| Immunogen Description: | Synthetic peptide: MNFLLSWVHWSLALLLYLHH, corresponding to amino acids 1-20 of Human VEGF. |
| Epitope: | request info |
| Specificity: | request info |
| Cross Reactivity: | Cross-reacts with Human.Expected to cross-react with Cow (100% identity with immunogen), Cat (100% identity with immunogen), Cynomolgus Monkey (100% identity with immunogen), Dog (100% identity with immunogen), Horse (100% identity with immunogen), Mink (100% identity with immunogen), Pig (100% identity with immunogen) and Sheep (100% identity with immunogen) due to sequence homology.Not yet tested in other species. |
| Form: | 6 millilitres |
| Uses: | ELISA: prediluted, ready to use. IHC-P: prediluted, ready to use. IP: Use at an assay dependent dilution. WB: prediluted, ready to use. Predicted molecular weight: 27 kDa. Not tested in other applications.Optimal dilutions/concentrations should be determined by the end user. |
| Cellular Localisation: | Secreted |
| Positive Control: | Epithelial cells of breast cancer tissue.Normal rabbit serum is provided with this product as a nega |
| Relevance: | request info |
| References: | request info |
| User Storage Instructions: | Store at 4 degrees C. Aliquot and store at -20 degrees C long-term. |
| Product Type Name: | Primary Antibody |
| Purity Description: | Protein A purified |
| SubClass: | IgG |
| Raised In: | Rabbit |
| Storage Buffer Description: | Preservative: 0.1% Sodium AzideConstituents: 1% BSA, 0.01M PBS |
| List Price: | 330 |
| General References: | General / background references:Brekken RA et al. Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res 58:1952-9 (1998). de Jong JS et al. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. J Pathol 184:53-7 (1998). Eppenberger U et al. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol 16:3129-36 (1998). |
| Novus References: | request info |
| Application Summary: | ELISA, IHC-P, IP, WB |
| Species Summary: | request info |
| Alternate Names: | request info |
| Package Size: | 6 ml |